Form 4: Celanese Director Plans Future Phantom Stock Acquisition
Insider Transaction Report
Celanese Corporation director Edward G. Galante reported a planned acquisition of 5.21 shares of phantom stock on November 12, 2025, through dividend equivalents under a 10b5-1 plan.
Summary
- Edward G. Galante, a Director of Celanese Corp (CE), filed a Form 4 reporting a planned transaction.
- The transaction involves the acquisition of 5.21 shares of phantom stock, representing dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan.
- The transaction is scheduled to occur on November 12, 2025.
- Each share of phantom stock represents the right to receive one share of Common Stock.
- The phantom stock was acquired at a price of $39.12 per share, totaling approximately $203.82.
- Following this planned transaction, Mr. Galante will beneficially own 6,802.765 shares of phantom stock directly.
- The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating it is a pre-arranged, non-discretionary transaction.
Sentiment
Score: 5
Explanation: The filing reports a routine, non-discretionary acquisition of phantom stock by a director through dividend reinvestment under a pre-existing deferred compensation plan. This type of transaction is neutral in sentiment as it reflects standard compensation practices rather than a discretionary investment decision or significant corporate event.
Positives
- The transaction represents a routine dividend reinvestment, indicating continued participation and alignment of the director's interests with shareholders through the company's deferred compensation plan.
- The use of a Rule 10b5-1 plan demonstrates a pre-arranged, transparent approach to insider transactions.
Risks
- The value of the phantom stock, and subsequently the common stock it represents, is subject to market fluctuations inherent in equity investments.
Future Outlook
The acquired phantom stock shares will become payable in shares of Celanese Common Stock, as provided in the Company's 2008 Deferred Compensation Plan, following the termination of Edward G. Galante's service as a director of the Company.
Industry Context
This is a routine insider transaction, common for directors participating in company deferred compensation plans, and does not reflect broader industry trends or competitive positioning. It is a standard disclosure for pre-planned equity acquisitions under Rule 10b5-1.
Comparison to Industry Standards
- This Form 4 details a specific insider transaction (dividend reinvestment) and does not provide company-wide performance metrics that would allow for direct comparison to industry standards or competitors' results.
Related Party Transactions
- The acquisition of phantom stock by a director (Edward G. Galante) from the company (Celanese Corp) under its 2008 Deferred Compensation Plan constitutes a related-party transaction, which is standard for executive and director compensation arrangements.
Stakeholder Impact
- Shareholders: Minimal direct impact, as it's a small, routine transaction for a director's deferred compensation.
- Employees: No direct impact mentioned.
- Customers/Suppliers/Creditors: No direct impact mentioned.
Next Steps
- The phantom stock will convert into shares of Common Stock upon the termination of the reporting person's service as a director.
Key Dates
| Date | Description |
|---|---|
| 11/12/2025 | Planned acquisition of 5.21 shares of phantom stock by Edward G. Galante. |
| 11/13/2025 | Date the Form 4 was signed and filed. |
Keywords
Celanese, CE, Form 4, Insider Transaction, Phantom Stock, Deferred Compensation, Director, Edward G. Galante, Dividend Reinvestment, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.